Terminated/Withdrawn

Diabetes Mellitus, Type 1

Bayer Identifier:

Trial_0665

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Efficacy and tolerability of acarbose (BAY g 5421) compared with placebo in diabetic children on conventional insulin treatment

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

6 - 16 Years

Trial summary

Enrollment Goal

Trial Dates

September 1991 - September 1993

Phase

Phase 3

Could I Receive a placebo

N/A

Products

Acarbose (Precose/Glucobay, BAYG5421)

Accepts Healthy Volunteer

N/A

Trial design

Clinical study on the efficacy and tolerability of acarbose (BAY g 5421) compared with placebo in diabetic children on conventional insulin treatment, in particular with observation of the glycemic control index.

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.